Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772]
EBioMedicine. 2024 Apr 4:103:105106.
doi: 10.1016/j.ebiom.2024.105106.
Online ahead of print.
1 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
2 Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
3 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: liwencai@zzu.edu.cn.
4 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: guozhongjiang@zzu.edu.cn.
5 Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: fcclixn@zzu.edu.cn.